Influence of allelic Variations of hypoxia-related and DNA repair genes on patient outcome and toxicity in head and neck cancer treated with radiotherapy plus cetuximab.

about

Association of Glutathione S-Transferase P-1 (GSTP-1) rs1695 polymorphism with overall survival in glioblastoma patients treated with combined radio-chemotherapy.

P2860

Q48089892-FDB0EA92-F999-426E-A3D1-F7CE042F99CF

P2860

Influence of allelic Variations of hypoxia-related and DNA repair genes on patient outcome and toxicity in head and neck cancer treated with radiotherapy plus cetuximab.

Item

http://www.wikidata.org/entity/Q41512181

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Influence of allelic Variation ...... h radiotherapy plus cetuximab.

@en

type

Item

label

Influence of allelic Variation ...... h radiotherapy plus cetuximab.

@en

prefLabel

Influence of allelic Variation ...... h radiotherapy plus cetuximab.

@en

P1476

Influence of allelic Variation ...... h radiotherapy plus cetuximab.

@en

P2093

Carmen Muñoz

http://www.w3.org/2001/XMLSchema#string

Eugenia Verger

http://www.w3.org/2001/XMLSchema#string

Juan Jose Grau

http://www.w3.org/2001/XMLSchema#string

Miguel Caballero

http://www.w3.org/2001/XMLSchema#string

Sofia Hakim

http://www.w3.org/2001/XMLSchema#string

P2860

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Differential impact of EGFR-targeted therapies on hypoxia responses: implications for treatment sensitivity in triple-negative metastatic breast cancer

Hypoxia--a key regulatory factor in tumour growth

Single-nucleotide polymorphisms in base excision repair, nucleotide excision repair, and double strand break genes as markers for response to radiotherapy in patients with Stage I to II head-and-neck cancer.

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.

HIF-2alpha-mediated activation of the epidermal growth factor receptor potentiates head and neck cancer cell migration in response to hypoxia.

Targeting nonhomologous end-joining through epidermal growth factor receptor inhibition: rationale and strategies for radiosensitization.

Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522.

Activation of tyrosine kinases in cancer.

P2888

s00405-015-3740-4

P304

2193-2199

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00405-015-3740-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

273

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26245169

http://www.w3.org/2001/XMLSchema#string

P921

cetuximab

Influence of allelic Variations of hypoxia-related and DNA repair genes on patient outcome and toxicity in head and neck cancer treated with radiotherapy plus cetuximab.

about

P2860

P2860

Influence of allelic Variations of hypoxia-related and DNA repair genes on patient outcome and toxicity in head and neck cancer treated with radiotherapy plus cetuximab.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921